CareRx (TSX:CRRX) - Stock Price, News & Analysis

CRRX Stock Overview

CareRx Corporation, together with its subsidiaries, provides pharmacy services to seniors homes and other congregate care settings in Canada.

About the company

CRRX fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Shareholders have been diluted in the past year

CareRx Corporation Competitors

Neighbourly Pharmacy

TSX:NBLY

CA$840.4m

ManifestSeven Holdings

CNSX:MSVN

CA$3.8m

Colabor Group

TSX:GCL

CA$118.3m

Ceres Global Ag

TSX:CRP

CA$96.1m

Price History & Performance

Summary of all time highs, changes and price drops for CareRx
Historical stock prices
Current Share Price	CA$2.38
52 Week High	CA$2.43
52 Week Low	CA$1.10
Beta	0.94
1 Month Change	25.26%
3 Month Change	50.63%
1 Year Change	5.31%
3 Year Change	-64.32%
5 Year Change	-48.26%
Change since IPO	-23.23%

Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?

Apr 22

Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher

Mar 17

Recent updates

Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?

Apr 22

Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher

Mar 17

Is CareRx Corporation's (TSE:CRRX) Shareholder Ownership Skewed Towards Insiders?

Mar 15

Trade Alert: The Chairman Emeritus Of CareRx Corporation (TSE:CRRX), Jack Shevel, Has Just Spent CA$850k Buying 9.4% More Shares

Feb 08

Reflecting on CareRx's (TSE:CRRX) Share Price Returns Over The Last Three Years

Dec 29

Is CareRx (TSE:CRRX) Using Too Much Debt?

Dec 03

Shareholder Returns

	CRRX	CA Consumer Retailing	CA Market
7D	8.2%	2.7%	0.7%
1Y	5.3%	9.4%	4.9%

Price Volatility

Is CRRX's price volatile compared to industry and market?
CRRX volatility
CRRX Average Weekly Movement	6.9%
Consumer Retailing Industry Average Movement	2.9%
Market Average Movement	9.0%
10% most volatile stocks in CA Market	18.1%
10% least volatile stocks in CA Market	3.0%

Volatility Over Time: CRRX's weekly volatility (7%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2001	1,559	Puneet Khanna	www.carerx.ca

CareRx Corporation, together with its subsidiaries, provides pharmacy services to seniors homes and other congregate care settings in Canada. The company offers medication management, technology, and program solutions. It serves long-term care homes, retirement homes, assisted living facilities, and group homes.

CareRx Corporation Fundamentals Summary

How do CareRx's earnings and revenue compare to its market cap?
CRRX fundamental statistics
Market cap	CA$143.05m
Earnings (TTM)	-CA$5.40m
Revenue (TTM)	CA$370.75m

0.4x

P/S Ratio

-26.5x

P/E Ratio

Is CRRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRRX income statement (TTM)
Revenue	CA$370.75m
Cost of Revenue	CA$266.05m
Gross Profit	CA$104.70m
Other Expenses	CA$110.10m
Earnings	-CA$5.40m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.09
Gross Margin	28.24%
Net Profit Margin	-1.46%
Debt/Equity Ratio	82.3%

How did CRRX perform over the long term?

See historical performance and comparison

CRRX Stock Overview

Rewards

Risk Analysis

CareRx Corporation Competitors

TSX:NBLY

CA$840.4m

CNSX:MSVN

CA$3.8m

TSX:GCL

CA$118.3m

TSX:CRP

CA$96.1m

Price History & Performance

Recent News & Updates

Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?

Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher

CareRx Corporation, Annual General Meeting, May 28, 2024

CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings: EPS misses analyst expectations

CareRx Corporation to Report Q4, 2023 Results on Mar 07, 2024

Recent updates

Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?

Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher

CareRx Corporation, Annual General Meeting, May 28, 2024

CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings: EPS misses analyst expectations

CareRx Corporation to Report Q4, 2023 Results on Mar 07, 2024

New major risk - Revenue and earnings growth

Third quarter 2023 earnings: EPS exceeds analyst expectations

CareRx Corporation to Report Q3, 2023 Results on Nov 08, 2023

CareRx (TSE:CRRX) Takes On Some Risk With Its Use Of Debt

What You Can Learn From CareRx Corporation's (TSE:CRRX) P/S

New major risk - Revenue and earnings growth

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

CareRx Corporation to Report Q2, 2023 Results on Aug 10, 2023

Less than half of directors are independent

Carerx Corporation Announces Director Changes

First quarter 2023 earnings released: CA$0.039 loss per share (vs CA$0.059 loss in 1Q 2022)

Consensus EPS estimates fall by 29%

Forecast breakeven date pushed back to 2025

Price target decreased by 11% to CA$5.23

Full year 2022 earnings released: CA$0.72 loss per share (vs CA$0.65 loss in FY 2021)

CareRx Corporation has completed a Follow-on Equity Offering in the amount of CAD 8.0001 million.

CareRx Corporation announced that it expects to receive CAD 8.0001 million in funding

CareRx Announces Retirement of Dr. Jack Shevel as Director Effective December 31, 2022

No longer forecast to breakeven

Price target decreased to CA$6.09

Less than half of directors are independent

Price target decreased to CA$6.15

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

CareRx Corporation to Report Q3, 2022 Results on Nov 09, 2022

CareRx (TSE:CRRX) Has A Somewhat Strained Balance Sheet

Consensus forecasts updated

Price target decreased to CA$6.93

Carerx Corporation Reports Goodwill and Intangible Assets Impairment Changes for the Three Months Ended June 30, 2022

CareRx Corporation to Report Q2, 2022 Results on Aug 15, 2022

President recently sold CA$230k worth of stock

CareRx Corporation (TSX:CRRX) completed the acquisition of Hogan Pharmacy Partners Ltd.

Consensus EPS estimates fall by 597%

Price target decreased to CA$8.52

These 4 Measures Indicate That CareRx (TSE:CRRX) Is Using Debt Extensively

Forecast breakeven date pushed back to 2024

CareRx Corporation to Report Q1, 2022 Results on May 11, 2022

Consensus forecasts updated

Less than half of directors are independent

CareRx Corporation Announces Executive Changes

CareRx Corporation, Annual General Meeting, Jun 07, 2022

CareRx Corporation (TSX:CRRX) entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd for $4.4 million.

CareRx Corporation (TSX:CRRX) entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd for $4.4 million.

Consensus forecasts updated

No longer forecast to breakeven

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Carerx Corporation Expands the Scope and Product Offering of Its Medical Supplies Business Under A New Brand, Revicare

Here's Why CareRx (TSE:CRRX) Has A Meaningful Debt Burden

Third quarter 2021 earnings released: CA$0.11 loss per share (vs CA$0.28 loss in 3Q 2020)

CareRx Corporation (TSX:CRRX) completed the acquisition of Long-Term Care Pharmacy Division of Medical Pharmacies Group Limited for CAD 72.9 million.

Consensus EPS estimates fall to -CA$0.72

Second quarter 2021 earnings released: CA$0.28 loss per share (vs CA$0.75 loss in 2Q 2020)

CareRx Corporation (TSX:CRRX) completed the acquisition of pharmacy fulfillment centre and portion of long-term care pharmacy services business of Rexall Pharma Plus Ltd.

Director Lyle Oberg has left the company